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Abstract
Human genetic studies have suggested that polymorphisms of the GABRA2 gene encoding the GABAA a2-subunit are
associated with ethanol dependence. Variations in this gene also convey sensitivity to the subjective effects of ethanol,
indicating a role in mediating ethanol-related behaviours. We therefore investigated the consequences of deleting the a2-
subunit on the ataxic and rewarding properties of ethanol in mice. Ataxic and sedative effects of ethanol were explored in
GABAA a2-subunit wildtype (WT) and knockout (KO) mice using a Rotarod apparatus, wire hang and the duration of loss of
righting reflex. Following training, KO mice showed shorter latencies to fall than WT littermates under ethanol (2 g/kg i.p.) in
both Rotarod and wire hang tests. After administration of ethanol (3.5 g/kg i.p.), KO mice took longer to regain the righting
reflex than WT mice. To ensure the acute effects are not due to the gabra2 deletion affecting pharmacokinetics, blood
ethanol concentrations were measured at 20 minute intervals after acute administration (2 g/kg i.p.), and did not differ
between genotypes. To investigate ethanol’s rewarding properties, WT and KO mice were trained to lever press to receive
increasing concentrations of ethanol on an FR4 schedule of reinforcement. Both WT and KO mice self-administered ethanol
at similar rates, with no differences in the numbers of reinforcers earned. These data indicate a protective role for a2-
subunits, against the acute sedative and ataxic effects of ethanol. However, no change was observed in ethanol self
administration, suggesting the rewarding effects of ethanol remain unchanged.
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Introduction
Human genetic studies have suggested that polymorphisms of
the GABRA2 gene encoding the GABAA a2-subunit are
associated with ethanol dependence in European American, white
American, American plains Indian tribe and Russian populations
[1,2,3,4], though, unsurprisingly, this association is not evident in
all populations [5,6]. Although c-aminobutyric acid A (GABAA)
receptors have been suggested to represent a primary target for
ethanol, the direct effects of ethanol at postsynaptic receptors are
achieved only at high concentrations unlikely to be achieved by
social drinkers (see [7] for review). Lower concentrations of
ethanol can, however, can affect inhibitory GABAergic transmis-
sion by increasing release of GABA [8] and the release of
neuromodulators which are active at the GABAA receptor, most
notably neurosteroids [9].
Since Edenberg et al’s original report [2], related or identical
variants in GABRA2 genes have also been associated with other
addictive behaviours, including cocaine abuse [10], heroin abuse
[11] and polydrug abuse [12,13]. That related haplotypes were
associated with several forms of addiction make it unlikely that
possession of a risk haplotype simply confers increased or
decreased sensitivity to ethanol. Indeed the same variations are
also associated with childhood conduct disorder [14,15] and with
increased impulsivity [16], behavioural traits that may contribute
to the development of addictive behaviours. There is also
emerging evidence that the influence of GABRA2 haplotypes on
the development of addictions is due to an interaction with early
life stress [11]. Since facilitated GABAergic transmission via a2-
subunit containing receptors contributes to the anxiolytic action of
benzodiazepines [17,18] and barbiturates [19] and deletion of the
a2-subunit gives rise to an anxious phenotype [19], genetic
variations may contribute to the ability to cope with early life
stress, and thus lead to an increased likelihood of addiction.
Nevertheless, there is also evidence that the same haplotypic
variations in GABRA2 may alter the subjective effects of ethanol
ingestion as measured by self-assessment of ethanol-related
sensations [20] and mood [21], and studies using a2-subunit
mutant mice suggest that alcohol consumption is influenced by the
manipulation even at socially relevant concentrations of ethanol
[22]. These findings suggest a more direct relationship between
ethanol and a2-subunit containing GABAA receptors and may be
resolved by considering the role of intermediate neurotransmitters.
For example, inhibition of neurosteroid synthesis (which is
activated by ethanol) attenuates differences between risk and
protective haplotypes [23], suggesting that ethanol may indirectly
facilitate transmission at a2-subunit containing receptors by
increasing levels of neurosteroids.
Animal experiments using manipulations of the a2-subunit
in vivo have also suggested a more direct GABA-ethanol interac-
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tion but currently yield somewhat contradictory results. Using a
knockout mouse model, deletion of the a2-subunit resulted in
decreased sedation in response to an acute ethanol challenge, as
measured by the loss of righting reflex [24], suggesting that the a2-
subunit conveys sensitivity to the sedative effects of ethanol
(though, curiously, it mediates stimulant effects of benzodiazepines
[25,26]). Mutations of the a2-subunit (S270I in transmembrane
region 2 (TM2), A291W in TM3 [27] and a2(S270H, L277A)
[22]) result in decreased ethanol potentiation of the GABA
response in Xenopus oocytes. Mice bearing the latter mutation show
reduced ethanol-induced locomotor activation and a correspond-
ing increase in sedative effects as measured by loss of righting
reflex [22]. Such results appear inconsistent with a decreased
ethanol potentiation of GABA responses and with the behavioural
data reported in knockout mice. Nevertheless these apparently
contradictory data do suggest a potential role for the GABAA a2-
subunit in several mechanisms that may contribute to the
development of dependence to ethanol, including acute subjective
responses to ethanol.
We therefore investigated the role of the GABAA a2-subunit in
ethanol related behaviours using a knockout mouse model. Acute
effects were investigated using tests of sedation, locomotor
activation and motor coordination, whilst motivation to consume
ethanol was tested using an operant oral self administration
procedure.
Methods
Ethics Statement
All experiments were carried out with a UK Home Office
project licence under the authority of the UK Animals (Scientific
Procedures) Act 1986 and in accordance with local guidelines.
Experiments were performed at the University of Sussex, which is
a designated facility according to the Act. Following the
experiments, except where stated otherwise, mice were killed by
CO2 inhalation which is an appropriate method under Schedule 1
of the UK Animals (Scientific Procedures) Act 1986.
Animals
Wildtype (WT) and knockout (KO) male mice were bred from
heterozygous pairings and maintained on a mixed 50% C57BL/6J
–50% 129SvEv background. a2-subunit KO mice were generated
as previously described [19]. Animals were housed in pairs under a
12 hr light/dark cycle (lights on at 7.00 AM) in a holding room
with controlled temperature (<21uC) and humidity (<50%).
Except where specified, animals had ad libitum access to standard
laboratory chow (Bekay Feeds, Hull, UK) and water within the
home cage. Mean body weight at the start of the experiment was
approximately 30 g.
Drugs
Ethanol (95%) was diluted in 0.9% saline to a concentration of
20% v/v and administered i.p. at varying volumes (maximum
20 ml/kg) to achieve the required dose.
Sedative and Ataxic Effects of Acute Administration
Rotarod. To assess motor coordination, WT and KO mice
(n = 10) were trained to remain on a rotating rod apparatus
(Rotarod; Ugo Basile, Comerio, Italy), revolving at 16 revolutions
per minute. Each animal had two 5 minute training sessions. The
following day, all animals were re-tested for their ability to
complete a 3 minute trial prior to drug administration. Animals
were injected with 2 g/kg ethanol and tested on the Rotarod at 20
minute intervals until two consecutive 3 minute trials were
completed without falling.
Statistical analysis. A two-way, repeated measures ANOVA, with
the between subject factor genotype and within subject factor
timepoint was used to evaluate potential genotype and ethanol
effects for the latency to fall, using SPSS statistics package. The
Greenhouse-Geisser correction was applied to correct for a
violation in the assumption of sphericity.
Wire hang. To assess motor strength, WT and KO mice
(n = 12) were trained to grip and hang onto a taut wire suspended
50 cm above the bench top. Training was considered complete
when each animal maintained grip on the wire for 60 seconds on
two occasions. The following day, all animals were injected with
2 g/kg ethanol and their ability to hang from the wire, as
measured by latency to fall, was recorded prior to and at 20, 40
and 60 minutes post-injection.
Statistical analysis. A two-way, repeated measures AN-
OVA with the between subject factor genotype and within subject
factor timepoint was used to evaluate potential genotype and
ethanol effects for the variable latency to fall. Data were log
transformed to correct for a violation of homogeneity of variance.
Loss of righting reflex. To assess the sedative effects of
ethanol, WT and KO mice (n = 12) were injected with 3.5 g/kg
ethanol. At intervals of one minute, mice were tested for their
ability to recover an upright posture within 10 seconds. The time
of loss of righting reflex and duration of loss were recorded.
Statistical analysis. Duration of loss of righting reflex was
compared between the genotypes using an independent samples
Student’s t-test.
Locomotor activity. After 20 minute habituation sessions to
the locomotor runways for 2 days, WT and KO mice (n = 8) were
injected i.p. with 0, 1, 2 or 3 g/kg and immediately placed in
circular runways to record locomotor activity for 5 minutes.
Ethanol doses were administered in a counterbalanced design, at 2
day intervals.
Statistical Analysis. Habituation data were analysed using a
two-way, repeated measures ANOVA comparing genotype and
habitation day. To determine ethanol effects on locomotor
activity, a two-way, repeated measures ANOVA with the between
subject factor genotype and within subject factor dose was used to
evaluate potential genotype and ethanol effects on locomotor
activity.
Motivation to Obtain Ethanol
Operant self administration. WT and KO mice (n = 8)
were food restricted to reduce body weights to 90% of free-feeding
weight, and trained to press a lever for 10% sucrose in mouse
operant chambers (Med Associates, Georgia, VT, USA) con-
structed of clear Perspex (18618615 cm), and contained in sound
and light attenuating cubicles. Each operant chamber possessed a
single house light located on the wall opposite the levers. The front
wall was fitted with a liquid dipper, located between 2
ultrasensitive mouse levers. Following an initial 15 hour training
session, which included the dark phase, the response requirement
to obtain 10% sucrose reinforcer was increased over consecutive
days (range 2–7) from FR1 to FR2 to FR4 in daily one hour
sessions. Motivation to consume ethanol was investigated using the
sucrose fading technique [28]: over the following sessions the
sucrose concentration was decreased and the ethanol concentra-
tion was increased as follows; 10% sucrose +3% ethanol; 10%
sucrose +5% ethanol, 7% sucrose +5% ethanol, 10% sucrose
+10% ethanol. The mice remained at each stage until reaching a
criterion of at least 30 reinforcers per session on 3 consecutive
days.
Alpha2 GABAA Receptor and Ethanol
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Statistical analysis. Sessions to criteria at each sucrose/
ethanol concentration were analysed using a Mann-Whitney U
test. A two-way, repeated measures ANOVA, with the between
subject factor genotype and within subject factor ethanol/sucrose
concentration was used to evaluate potential genotype and
reinforcer effects for the number of lever presses and number of
reinforcers obtained. The Greenhouse-Geisser correction was
applied to correct for a violation in the assumption of sphericity.
Blood Ethanol Concentration
WT and KO mice (n = 4 per time point) were administered
ethanol (2 g/kg, i.p.) acutely. At 15, 45 and 120 minutes following
administration, mice were sacrificed by cervical dislocation and
trunk blood collected into heparinised capillary tubes. Blood
samples were centrifuged for 10 minutes and supernatant frozen at
280uC. Samples were analysed in triplicate using an Analox
automatic ethanol analyser (AM1, Analox Instruments, London,
UK) and the mean value taken for statistical analysis.
Statistical analysis. A two-way, repeated measures AN-
OVA, with the between subject factors genotype and sampling
time was used to evaluate potential genotype and timepoint effects
for the variable ethanol level.
Results
Sedative and Ataxic Effects of Acute Administration
Rotarod. Prior to receiving an ethanol injection, all animals
were able to complete a 3 minute trial on the Rotarod apparatus.
After administration of ethanol, both genotypes improved their
performance over the course of the experiment (Main effect of
time; F(6,108) = 26.702, p,0.001, e=0.604; Fig. 1A). However,
KO mice were more impaired in their performance (main effect of
genotype, F(1,18) = 13.775, p,0.01) and were slower to recover the
ability to remain on the Rotarod for 180 seconds (genotype by
time interaction, F(6,108) = 3.703, p,0.05, e=0.604).
Wire hang. Prior to ethanol administration, both genotypes
demonstrated a similar degree of motor strength and remained on
the wire for a comparable amount of time. (t(22) =20.007,
p = 0.995; Fig. 1B). However, after 2 g/kg ethanol, KO mice
showed a marked decrease in the time spent on the wire compared
to WT (genotype by time interaction, F(2,44) = 3.133, p = 0.05) but
both genotypes recovered within a similar time frame.
Loss of righting reflex. After administration of 3.5 g/kg
ethanol, KO mice showed increased sedation compared to WT
(t(22) =24.4, p,0.001), as measured by a longer duration of the
loss of righting reflex (Fig. 1C).
Locomotor activity. No genotype differences were noted
during habituation to the locomotor apparatus (genotype by dose
interaction, F(1,14) = 0.598, p= 0.452; main effect of genotype,
F(1,14) = 0.268, p= 0.613; data not shown). Locomotor activity at
five minutes after ethanol administration was lower in KO mice
compared to WT (genotype by dose interaction, F(3,39) = 3.075,
p,0.05; Fig 1D).
Motivation to Obtain Ethanol
Operant self-administration. The acquisition of self ad-
ministration of sucrose and ethanol solutions did not differ
between genotypes. Both genotypes performed a similar number
of sessions to criterion at each concentration (10%0%: U=31.5,
p = 0.648; 10%3%: U=28.0, p = 1.00; 10%5%: U=22.5,
p = 0.448; 7%5%: U=27.5, p= 0.951; 10%10%: U=28.0,
p = 1.00; Fig. 2A). When allowed to lever press to gain access to
increasing concentrations of ethanol in a sucrose solution, KO
mice did not differ from WT in either the number of active lever
presses (genotype by reinforcer interaction, F(4,52) = 0.721,
p = 0.486, e=0.462; main effect of genotype, F(1,13) = 0.019,
p = 0.893; Fig. 2B) or the number of reinforcers earned (genotype
by reinforcer interaction, F(4,52) = 0.486, p = 0.604, e=0.456; main
effect of genotype, F(1,13) = 0.034, p = 0.858; Fig. 2C) in 30
minutes. The genotypes performed to a similar level at all
concentrations, both reducing their number of reinforcers as the
ethanol concentration increased (Main effect of concentration,
F(4,52) = 12.357, p,0.001, e=0.456).
Blood Ethanol Concentration
A significant main effect of post-administration sampling time
(F(2,15) = 26.18, p,0.001; Fig. 3) indicates that amount of ethanol
in the blood decreases over time. Both main effect of genotype
(F(1,15) = 0.191, p= 0.668) and genotype by sampling time inter-
action (F(2,15) = 0.005, p = 0.995) were non-significant, indicating
that the rate of ethanol metabolism is similar in both genotypes.
Discussion
The current data suggest a role for the GABAA a2-subunit in
mediating the sedative and ataxic effects of acute ethanol
administration. Deletion of this subunit resulted in a decreased
ability to maintain walking on a Rotarod apparatus under ethanol
treatment, decreased motor strength as measured in the wire hang
test, and a greater duration of the loss of righting reflex. In
response to an acute ethanol challenge, KO animals showed lower
locomotor activity compared to WT at the highest dose, further
suggesting increased sedation in the KO. It should be noted that
locomotor activity was measured for five minutes immediately
following ethanol injection, to capture the period during which
ethanol is activating. Thus, the doses administered to induce
locomotor activity may seem high in comparison to other
publications that emphasise the sedative effects of the drug. Since
metabolism was unaffected, the effects observed indicate an
increased sensitivity to the sedative and ataxic effects of ethanol. In
spite of the observed acute difference, no change in the motivation
to consume an ethanol solution was observed, suggesting this
increased sensitivity does not extend to the rewarding properties of
ethanol.
GABAA receptors are expressed throughout the CNS, with
different receptor subtypes providing heterogeneous expression
throughout distinct brain regions. Whilst the exact neural basis for
the sedative and ataxic affects of ethanol is currently unknown, the
a2-subunit is expressed within brain areas involved in motor
output, namely the striatum, cerebellum [29,30] and within the
dorsal and ventral horns of the spinal cord [31,32], making these
the most likely loci to mediate acute sedative/ataxic effects.
There are several mechanisms by which a manipulation of
GABAergic inhibition may affect responses to ethanol. Ethanol
can activate postsynaptic receptors directly at high concentrations
but whether this effect occurs at concentrations likely to be
achieved socially is controversial [7]. Thus loss of GABAA a2-
subunits is unlikely to change ethanol responses in the current
experiments which result in relatively low blood alcohol
concentrations, but currently cannot be ruled out as a possibility.
These lower concentrations, however, can induce release of
neurosteroids, which are known to act at GABAA receptors. The
actions of neurosteroids have been shown to be only modestly
influenced by the a-subunit composition of the receptor, with an
alteration of the c-subunit having the most effect [33].
Furthermore, changes in neurosteroid levels do not appear to
alter the acute motor effects of ethanol [34], suggesting that a
neurosteroid-dependent mechanism is unlikely to explain the
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acute differences observed in the current study. Increased GABA
release also occurs in response to ethanol administration and is
induced, at least in part, by a presynaptic GABAA receptor
mechanism [35,36]. The a2-subunit has been found presynap-
tically in hippocampal mossy fibre neurons [37] and thus may
serve to modulate GABA release. Since presynaptic GABA
receptors attenuate ethanol-induced GABA release [36], it might
be speculated that a deletion of the a2-subunit would result in
increased GABA release in response to an ethanol challenge,
causing an enhanced acute response. However, it is important to
note that evidence of presynaptically expressed a2-subunits in
brain regions other than hippocampus, and a direct link with
ethanol effects remains to be demonstrated.
In spite of acute differences to the sedative and ataxic effects,
motivation to drink as measured by operant self-administration of
an oral ethanol solution remained unchanged in KO mice. The
increased sensitivity to the motor effects of ethanol in the KO did
not appear to affect the ability to obtain the solution since both
genotypes self administered at a similar rate for all concentrations
and neither genotype indicated an inability to perform due to
inebriation. Importantly, the absence of a change in ethanol self-
administration is consistent with previously published data using
KO mice, which showed no differences in ethanol drinking
Figure 1. Increased ataxia and sedation after acute ethanol administration in GABAA a2-subunit KO mice. (A) Latency (secs) to fall from
the Rotarod apparatus. WT mice are able to remain on the Rotarod apparatus for longer than KO after 2 g/kg ethanol (n = 10; genotype by time
interaction, F(6,108) = 3.703, p,0.05, e=0.604) (B) Latency (secs) to fall from the wire hang apparatus. WT mice are able to retain a grip on the hanging
wire longer than KO mice after 2 g/kg ethanol. (n = 12; genotype by time interaction, F(2,44) = 3.133, p = 0.05) (C) Loss of righting reflex. KO animals
show a longer duration of sedation after 3.5 g/kg ethanol (n = 12; t(22) =24.4, p,0.001) (D) Locomotor dose response. KO animals show reduced
locomotion at 5 mins after 3 g/kg ethanol when compared to WT animals (n = 8; genotype by dose interaction, F(3,39) = 3.075, p,0.05).
doi:10.1371/journal.pone.0047135.g001
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preference as measured by a two-bottle choice paradigm [24].
However, a point mutation of the a2-subunit gave rise to varying
effects on ethanol drinking depending on the precise test
conditions, with the mutant drinking more alcohol during short-
term daily access and less alcohol during continuous access [22].
Whilst these findings imply an involvement of the a2-subunit in
ethanol drinking, they are difficult to interpret without further
investigations of factors such as taste reactivity, withdrawal or
motivational effects. Given the regional distribution of the a2-
subunit, it is perhaps not surprising that motivated drinking, as
measured by operant self-administration, is unaffected by its
deletion. In contrast to psychostimulants, lesions of the striatum
(where the a2-subunit is heavily expressed) do not affect
motivation to consume ethanol [38,39]. Instead, it has been
suggested that the ventral pallidum may be more important in
maintaining ethanol drinking, consistent with a role of the GABAA
a1-subunit [40,41] which is more abundant within this region.
The lack of an effect of a gabra2 deletion on drinking behaviour
seems at first sight to be in disagreement with the human literature
suggesting that polymorphisms of the a2-subunit are involved in
ethanol dependence [1,2]. Both risk and protective haplotypes
have been identified, but it is currently unknown if and how these
haplotypes translate into expression differences and if they would
be in any way analogous to the constitutive mouse knockout. One
factor that should be considered is how variations in the a2-
subunit may interact with other intrinsic or environmental
influences. Recent evidence suggests that the a2-subunit plays a
role in ethanol dependence only in those who have been subjected
to childhood trauma [11]. Since our mice received no develop-
mental stress, it is perhaps unlikely that they would reveal a role of
a2-subunit containing receptors in motivation to drink ethanol.
An important consideration of any experiment using a
constitutive knockout model is that compensatory changes may
take place in response to the deletion, potentially causing changes
in receptor function that will have occurred throughout the brain
and during development and may be responsible for the resulting
changes in phenotype. Certainly, in the case of deletion of the
gabra1 gene resulting in loss of the a1-subunit, there is evidence for
increased expression of a2- and a3-subunits, and decreased
expression of c2-subunits, as well as alterations in receptor
clustering and distribution [42,43] and in various other genes
involved in neural plasticity [44]. Using quantitative PCR analysis,
we found no evidence for altered expression of other GABAA
receptor subunits in the KO [10], indicating a lack of compen-
sation in subunit expression at the transcription level in the adult
mouse. Nevertheless we cannot exclude changes either at the
protein level, or patterns of insertion of receptors into the
membrane, or to other neurotransmitter systems.
Such compensatory changes may be important when compar-
ing data from other mutant mouse models. Differing mutations of
the a2-subunit have resulted in both increased sedation in
response to an ethanol challenge (S270H, L277A mutant [22])
and decreased sedation (H101R mutant [45]). The difference
between these studies and the current data may be explained by a
difficulty in identifying the mechanism by which ethanol is
affecting GABAA transmission. Whether it is a direct mechanism
or secondary effects via other neuromodulators, such as neuro-
steroids, manipulating different amino acid residues within the
Figure 2. Self administration of sucrose/ethanol solution remains unchanged in GABAA a2-subunit KO mice. (A) Sessions to criteria.
The genotypes did not differ in their acquisition of self administration, performing a similar number of sessions to criteria at each concentration of
ethanol (n = 8; 10%0%: U= 31.5, p = 0.648; 10%3%: U= 28.0, p = 1.00; 10%5%: U= 22.5, p = 0.448; 7%5%: U= 27.5, p = 0.951; 10%10%: U= 28.0,
p = 1.00) (B) Number of active lever presses. Both genotypes perform a comparable number of lever presses to obtain increasing concentrations of
ethanol in a sucrose/ethanol solution (genotype by reinforcer interaction, F(4,52) = 0.721, p = 0.486, e= 0.462) (C) Number of reinforcers earned. Both
WT and KO mice earned a similar number of reinforcers at each concentration of ethanol (genotype by reinforcer interaction, F(4,52) = 0.486, p = 0.604,
e= 0.456), indicating that motivation to obtain ethanol is unchanged after a deletion of the GABAA a2-subunit.
doi:10.1371/journal.pone.0047135.g002
Figure 3. Blood ethanol concentration. Following an acute ethanol
challenge (2 g/kg, i.p.), no genotype differences were observed in blood
ethanol concentration (n = 4; genotype by sampling time interaction
F(2,15) = 0.005, p = 0.995).
doi:10.1371/journal.pone.0047135.g003
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subunit may produce a variation in the receptor responses.
However, it is noteworthy that a point mutation in a2-subunits
(serine 270 to histidine and leucine 277 to alanine mutations)
resulting in reduction of sensitivity to ethanol’s ability to facilitate
GABA-induced current, when expressed in mice also enhanced
ethanol’s effects on the loss of the righting reflex, without
influencing ethanol consumption [22]. Since point mutations
may be less likely to give rise to compensatory changes (but see
[17]) than deletions, such a result would be consistent with the
behavioural effects we observed being due to loss of a2-subunit
function, and not to compensatory effects.
It is important to note that previous experiments using gabra2
KO mice have shown a decrease in sensitivity to the acute effects
of ethanol as shown by a reduced loss of righting reflex [24], the
direct opposite response to the one reported here. The discrepancy
between this experiment and the current data are not attributable
to differences in generation of the knockout, as in both cases the
mice were derived from the same original line [19,24]. Further-
more, the two knockout colonies have both been maintained on
the same background strain (50% C57BL/6J, 50% 126SvEv)
which minimises the possibility of differences in epistatic interac-
tions with genes from the background strain influencing the
behaviour. At present, we can only suggest that differences may
reflect consequences of genetic drift within two independently-
maintained colonies.
In conclusion, the current data demonstrate that deletion of the
gabra2 gene encoding the GABAA a2-subunit results in an
increased sensitivity to the acute sedative and ataxic effects of
ethanol administration, without changing the motivation to
consume ethanol. In conclusion, these observations imply a
protective role of the a2-subunit against the acute motor effects
of high dose ethanol but the exact mechanism remains unclear.
Whilst genetic variations of the GABRA2 gene in humans have
previously implicated this subunit in ethanol abuse, current data
suggest that this is unlikely to be due to GABAergic manipulations
directly changing motivational behaviour. Considering the com-
plexity of the literature regarding the potential role of the GABAA
a2-subunit in responses to ethanol, it may be important to
consider the participation of intermediate messenger systems. In
the case of a role for variations in a2-subunit containing receptors
as risk factors for addiction, additional factors, such as stress, and
how they interact with GABAergic inhibition may be important in
producing addiction-related phenotypes.
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